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Qiwei Zhang1,2, Leslie A. Sitzman3, Mohammad Al-Hassani1,2, Shanbao Cai2, Karen E. Pollok2,4,
Jeffrey B. Travers1,2,4,5 and Cynthia M. Hingtgen3,5,6
Ultraviolet B (UVB) radiation causes cutaneous inflammation. One important clinical consequence of
UVB-induced inflammation is increased pain or hyperalgesia, which is likely mediated by enhanced sensitivity
of cutaneous sensory neurons. Previous studies have demonstrated that UVB radiation generates the lipid
mediator, platelet-activating factor (PAF), as well as oxidized phospholipids that act as PAF-mimetics. These
substances exert effects through the PAF receptor (PAF-R). This study was designed to assess whether PAF-R is
involved in UVB-induced hyperalgesia. Intradermal injection of carbamoyl PAF (CPAF; 1-hexadecyl-2-N-
methylcarbamoyl glycerophosphocholine) resulted in an enhanced response to mechanical stimuli in wild-type
mice but not in PAF-R knockout (KO) mice. There was no significant change in paw withdrawal to noxious
thermal stimuli in either genotype after intradermal injection of CPAF. Exposure of the hind paw to 1,500 Jm2
UVB radiation caused an increased sensitivity to both mechanical and thermal stimulation in wild-type mice but
not in PAF-R KO mice. The thermal hyperalgesia caused by UVB irradiation was inhibited in mice that lacked
PAF-R in bone marrow-derived cells. These data demonstrate that the PAF-R is important for UVB-induced
hyperalgesia. Further investigation of the role of PAF-R signaling in UVB-induced hyperalgesia could provide
better understanding of the pathological processes initiated by UVB-induced skin damage.
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INTRODUCTION
Ultraviolet B (UVB, 290–320 nm) irradiation has profound
effects on human skin, causing cutaneous inflammation and
cell death. Acute short-term UVB irradiation of keratinocytes
produces oxidative stress and DNA damage (Norins, 1962;
Stewart et al., 1996). UVB irradiation, acting as a potent pro-
oxidative stressor (Peus et al., 1998), induces the production
of many cytokines, including tumor necrosis factor-a (TNF-a),
IL-1b, IL-6, IL-8, IL-10, and prostaglandins (reviewed by
Ullrich 1995; Leverkus et al., 1998). These inflammatory
cytokines have been implicated in UVB-induced inflamma-
tion and epidermal cell apoptosis.
In addition to its ability to induce the production of protein
cytokines, UVB irradiation also induces the production of the
lipid mediator, platelet-activating factor (PAF, 1-alkyl-2-
acetyl-glycero-3-phosphocholine) and PAF-mimic species,
through photooxidization of cellular polyunsaturated phos-
phatidylcholine, from epidermal cells (Barber et al., 1998;
Marathe et al., 2005). PAF is a potent activator of many cell
types, including platelets, monocytes, polymorphonuclear
leukocytes, mast cells, and vascular endothelium, and exerts
its biological effects through a single, highly specific
G-protein-coupled receptor, PAF receptor (PAF-R) (reviewed
by Ishii et al., 2002; Zimmerman et al., 2002). The PAF-R is
linked to numerous signal transduction pathways and a wide
range of pathological conditions including oxidative damage
and bacterial infection. Human keratinocytes express func-
tional PAF-Rs (Travers et al., 1995), and intradermal injection
of PAF induces cutaneous inflammation (Hellewell and
Williams, 1989; Travers et al., 1998a). Increased levels of
PAF (3 ngml1) are found in the fluid of human blisters
caused by inflammatory skin diseases such as bullous
pemphigoid or pemphigus vulgaris compared with levels
(0.5 ngml1) in noninflammatory blister caused by suction
(Travers et al., 1998b) Activation of PAF-R stimulates the
synthesis of various inflammatory cytokines, including TNF-a,
IL-1, IL-6, IL-8, IL-10, and eicosanoids (Roth et al., 1996;
Poubelle et al., 1991; Ruis et al., 1991; Aepfelbacher et al.,
1992), thus playing a key role in inflammatory processes.
There are reports suggesting that PAF may play a role in
pain signaling. PAF-R mRNA is present in mouse dorsal root
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ganglia and dorsal horn of the spinal cord (Morita et al.,
2004). Injection of PAF into the rat hind paw increases
sensitivity to mechanical stimulation, a phenomenon known
as hyperalgesia (Dallob et al., 1987). PAF-R antagonists can
block the hyperalgesia induced by Bothrops jararaca venom
(Teixeira et al., 1994) or formalin (Teather et al., 2002). Many
compounds released during tissue damage and inflammation
can induce hyperalgesia to mechanical stimuli or pressure,
thermal stimuli, or both by increasing the sensitivity of
cutaneous sensory neurons (Treede et al., 1992). Addition-
ally, Tusada et al. (2007) recently demonstrated that mice
with a lack of PAF-R have diminished hyperalgesic responses
to the injection of the noxious and inflammatory substances,
formalin and capsaicin. It is not clear from the few published
studies whether PAF-induced hyperalgesia is mediated by
direct actions of the agent on sensory neurons that transmit
pain signals, that is, nociceptors, or instead, if the hyper-
algesia is a result of PAF-induced inflammation.
As one of the important biological effects of UVB-induced
pathological responses is hyperalgesia, this study was
designed to assess whether the PAF-R and UVB-produced
PAF-mimetics are involved in UVB-induced hyperalgesia. As
there is a lack of effectively selective PAF-R antagonists, PAF-R
knockout (KO) mice generated by Ishii and colleagues (Ishii
et al., 1998) were used. Our results demonstrate that
administration of the stable PAF agonist, carbamoyl-PAF
(CPAF; 1-hexadecyl-2-N-methylcarbamoyl glycerophospho-
choline), causes mechanical hyperalgesia in the wild-type
but not PAF-R KO mice. Furthermore, both the mechanical
and thermal hyperalgesia induced by UVB irradiation were
attenuated by a lack of PAF-R in the KO mice. The
mechanical hyperalgesia induced by UVB irradiation was
preserved by either the presence of PAF-R in bone marrow-
derived cells or non-bone marrow-derived cells, as demon-
strated in mice undergoing bone marrow transplant. In
contrast, the absence of PAF-R in bone marrow-derived cells
inhibited the thermal hyperalgesia caused by UVB irradia-
tion. These data suggest an important role for PAF-R in UVB-
induced hyperalgesia.
RESULTS
CPAF induces mechanical hyperalgesia
Activation of PAF-R in epidermal cells has been found to
stimulate the synthesis of TNF-a and prostaglandins (Ruis et al.,
1991; Aepfelbacher et al., 1992), which are known to enhance
the sensitivity of cutaneous sensory neurons (Richardson and
Vasko, 2002). To assess whether activation of skin PAF-R
induces hyperalgesia, the hind paws of PAF-R-expressing wild-
type mice and PAF-R KO mice were intradermally injected
with the PAF-R agonist CPAF or vehicle control. Concentrations
of 50 and 250ng were chosen on the basis of previous
investigations that demonstrated a maximum effect of CPAF to
induce calcium influx in human keratinocyte-derived cell lines
between 50 and 500ng (Zhang et al., 2005) and the ability of
100ng of CPAF to reproducibly cause inflammation when
injected into the rodent ear skin (Travers et al., 1998b). Paw
withdrawal in response to the force of Von Frey hairs (g), a
measure of mechanical nociception, was measured before and
4 and 16hours after injection. As shown in Figure 1, the force
eliciting paw withdrawal before intradermal injection was
similar between PAF-R-expressing and KO mice. Injection of
50ml of 0.25% BSA vehicle did not alter the withdrawal
threshold in mice of either genotype. Intradermal injection of
50ng of CPAF in wild-type mice induced a significant decrease
in the force that elicited paw withdrawal (3.4±0.3g compared
with 1.5±0.7g before and 16hours after injection, respec-
tively, n¼6, Po0.05, using a repeated-measures analysis of
variance (ANOVA) with Dunnet’s post-hoc analysis). Injection
of 250ng CPAF in wild-type mice caused a similar decrease in
withdrawal threshold 16hours after injection (2.9±0.4g
compared with 1.3±0.4g, before and after injection, respec-
tively, n¼9, Po0.05, using a repeated-measures ANOVA with
Dunnet’s post-hoc analysis); moreover, a significant decrease in
withdrawal threshold was also observed 4hours after treatment
(2.9±0.4 g compared with 1.4±0.5 g, before and after
injection, respectively). No paw swelling or abnormal gait
was observed in any of the CPAF or vehicle-injected mice, and
there was no difference in baseline response to mechanical
stimulation between genotypes. These data demonstrate that
activation of skin PAF-R in wild-type mice induces mechanical
hyperalgesia, and the effect of CPAF is dose- and time-related.
In contrast, intradermal injection of 250ng CPAF into the hind
paws of PAF-R KO mice did not alter the paw withdrawal
threshold to mechanical stimulation, demonstrating the
requirement for PAF-R in the induction of mechanical
hyperalgesia caused by the PAF agonist.
CPAF alone does not induce thermal hyperalgesia
Different subclasses of nociceptive sensory neurons can
mediate mechanical and thermal stimuli (Besson and
Chaouch, 1987). For this reason, the induction of thermal
hyperalgesia and mechanical hyperalgesia are not always
elicited in the same manner. To evaluate whether activation
of skin PAF-R with CPAF intradermal injection induces
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Figure 1. Intradermal injection of CPAF induces mechanical hyperalgesia in
wild-type but not PAF-R KO mice. Columns represent the mean±SEM force
of Von Frey hair that caused paw withdrawal before (open columns) and
4hours (gray columns) and 16hours (black columns) after intradermal
injection of BSA or CFAP (50ml volume) into the hind paw. An asterisk
indicates a statistically significant difference from pretreatment levels using
a repeated-measures ANOVA with Dunnet’s analysis (*Po0.05).
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thermal hyperalgesia in mice hind paws, the latency of paw
withdrawal in response to heat-producing lamp was mea-
sured after CPAF injection in mice hind paws. As shown in
Figure 2, there was no difference in baseline response to
thermal stimulation between genotypes. Moreover, there was
no significant change in paw withdrawal latency observed in
either wild-type or PAF-R KO mice 4 and 16 hours after
injection with 250 ng of CPAF. These results suggest that
activation of skin PAF-R alone is not sufficient to induce
thermal hyperalgesia in mice.
UVB irradiation induces greater mechanical and thermal
hyperalgesia in skin in PAF-R-expressing wild-type mice in
comparison with PAF-R KO mice
Increased pain sensitivity of skin is one of the major
symptoms of acute UV exposure. It has been found that
UVB irradiation of epidermal cells or cellular phospholipid
produces PAF-mimetic species that activate epidermal PAF-R
(Walterscheid et al. 2002; Marathe et al., 2005). Human
sunburn is thought to start occurring at UVB irradiation
exposures in the range between 400 and 800 Jm2 (Autier
et al., 2000). To determine whether PAF-R is involved in
UVB-induced hyperalgesia, responses of wild-type and
PAF-R KO mice to thermal and mechanical stimulation were
measured before and after exposure to UVB irradiation. The
mice were restrained without anesthesia and one hind paw
was exposed to 1,500 Jm2 UVB irradiation. At this dose,
there was neither paw swelling nor abnormal gait observed in
any of the UVB-irradiated mice. The paw withdrawal in
response to mechanical or thermal stimulation was measured
before and 4 and 28 hours after irradiation as described
previously (Chaplan et al., 1994; Evans et al., 2000).
As shown in Figure 3, UVB irradiation in wild-type mice
induced a significant decrease in the force that elicited paw
withdrawal 4 and 28 hours after UVB irradiation (3.3±0.2,
1.2±0.4, 1.6±0.5 g, before and 4 and 28 hours after
UVB irradiation, respectively, n¼9, Po0.05, using a
repeated-measures ANOVA with Dunnet’s post-hoc analy-
sis). In contrast, there was a small but not statistically
significant decrease observed in PAF-R KO mice either 4 or
28 hours after UVB irradiation (3.1±0.3, 1.9±0.5, and
2.0±0.5 g, before and 4 and 28 hours after UVB irradiation,
respectively). These data suggest that PAF-R activation is
involved in the optimal induction of UVB-mediated mechan-
ical hyperalgesia in murine skin.
The next studies examined the role of the PAF-R in
UVB-mediated thermal hyperalgesia. Although intradermal
injection of CPAF did not induce thermal hyperalgesia
in wild-type mice, UVB irradiation of PAF-R-expressing
wild-type mice significantly shortened the withdraw latency
in response to thermal stimulation 4 and 28 hours after
treatment (Figure 4). In response to thermal stimulation, the
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Figure 2. Intradermal injection of CPAF does not induce thermal
hyperalgesia. Columns represent the mean±SEM (n¼ 4 mice per group) paw
withdrawal latency in seconds 4 hours (gray columns) and 16 hours (black
columns) after intradermal injection of BSA or CFAP (specific PAF-R agonist,
50ml volume) into the hind paw. There were no statistically significant
differences between groups using a repeated-measures ANOVA.
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Figure 3. Ultraviolet B irradiation induces mechanical hyperalgesia in
wild-type but not PAF-R KO mice. Columns represent the mean±SEM (n¼ 9
mice per group) force of Von Frey hair that caused paw withdrawal before
(open columns), 4 hours (gray columns) and 28hours (black columns) after
exposure to 1,500 Jm2 UVB radiation. An asterisk indicates a statistically
significant difference from pretreatment levels using a repeated-measures
ANOVA with Dunnet’s analysis (*Po0.05).
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Figure 4. Ultraviolet B irradiation induces thermal hyperalgesia in wild-type
but not PAF-R KO mice. Columns represent the mean±SEM (n¼ 9 mice per
group) paw withdrawal latency 4 hours (gray columns) and 28hours (black
columns) after exposure to 1500 Jm2 UVB radiation. An asterisk indicates a
statistically significant difference between genotypes at a particular time point
using a repeated-measures ANOVA with Dunnet’s analysis (*Po0.05).
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wild-type mice withdrew the paw after 10.6±0.6 seconds
exposure to radiant heat before UVB irradiation and at
5.6±0.9 seconds 4 hours after UVB irradiation and at
6.8±1.3 seconds 28 hours after UVB irradiation (n¼9,
Po0.05, a repeated-measures ANOVA with Dunnet’s post-
hoc analysis). Again, there was a small but not statistically
significant change in withdrawal latency observed in PAF-R
KO mice after UVB irradiation at 4 or 28 hours (withdrawal
latency of 8.9±0.6 seconds before and 6.0±0.5 and
7.6±1.0 seconds 4 and 28 hours after UVB exposure,
respectively, n¼ 9). These results demonstrate that the PAF-R
is also involved in the thermal hyperalgesic response induced
by UVB irradiation of mouse skin. High-dose UVB
(7,500 Jm2) resulted in identical hyperalgesic responses to
thermal and mechanical stimulation in both genotypes and
caused significant paw tissue damage and swelling (data not
shown). These findings fit with the notion that PAF is but one
mediator involved in UVB-mediated hyperalgesia.
The importance of the presence of PAF-R in bone
marrow-derived cells for UVB-mediated hyperalgesia
To determine which types of cells in the skin are needed in
UVB-induced hyperalgesia mediated by PAF-R, chimeric
mice were produced using bone marrow transplantation. This
allowed for the construction of mice with PAF-R on all but
bone marrow-derived cells and mice with PAF-R only on
bone marrow-derived cells. As a control, bone marrow from
wild-type mice was also transplanted into wild-type mice to
determine if irradiation and transplantation procedure itself
altered thermal or mechanical sensitivities.
Four months after the transplantation, mice were tested for
mechanical and thermal sensitivity before and after UVB
irradiation as described above. There were no differences in
baseline mechanical or thermal sensitivity between wild-type
mice receiving wild-type bone marrow, wild-type mice
receiving PAF-R-deficient bone marrow or PAF-R KO mice
receiving wild-type bone marrow (Figures 5 and 6). In
addition, there were no significant differences in baseline
behavioral responses of these groups and those of the animals
in the previous CPAF or UVB treatments.
As demonstrated in Figure 5, UVB irradiation caused a
significant reduction in the mechanical force needed to
induce paw withdrawal in all groups. The responses were
similar regardless of which cell compartments contained
PAF-R. These data suggest that while the presence of PAF-R
is necessary for the full development of mechanical
hyperalgesia after UVB irradiation, it is likely that there are
many PAF-R positive cells that can function in this response.
In contrast, UVB-induced thermal hyperalgesia was inhibited
in the absence of PAF-R in bone marrow-derived cells
(Figures 6), suggesting that cells of the hematological
system must contain PAF-R for UVB radiation to have its full
effect on thermal hyperalgesia.
DISCUSSION
It has been demonstrated that PAF has significant proin-
flammatory effects, including the synthesis of various
inflammatory cytokines and stimulation of numerous signal
transduction systems. In this study, we first investigated
whether PAF and PAF-R system are involved in UVB-induced
hyperalgesia in mice. It was shown that activation of skin
PAF-R by intradermal injection of CPAF, a metabolically
stable PAF-R agonist, induced mechanical hyperalgesia in a
time- and dose-related manner in wild-type mice. In contrast,
there was no hyperalgesic effect observed in PAF-R KO mice
after CPAF injection, confirming that PAF-R is necessary
for CPAF-mediated mechanical sensitization. No change in
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Figure 5. Ultraviolet B-induced mechanical hyperalgesia requires PAF-R in
either bone marrow-derived or non-bone marrow-derived cells. Columns
represent the mean±SEM (n¼ 6–10 mice per group) force of Von Frey
hair that caused paw withdrawal before (open columns), and 4hours
(gray columns) and 28hours (black columns) after exposure to 1,500 Jm2
UVB radiation. An asterisk indicates a statistically significant difference
from pretreatment levels using a repeated-measures ANOVA with Dunnet’s
analysis (*Po0.05).
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Figure 6. Ultraviolet B-induced thermal hyperalgesia is inhibited in the
absence of PAF-R in bone marrow-derived cells. Columns represent the
mean±SEM (n¼ 6–10 mice per group) paw withdrawal latency 4 hours
(gray columns) and 28hours (black columns) after exposure to 1,500 Jm2
UVB radiation. An asterisk indicates a statistically significant difference
between genotypes at a particular time point using a repeated-measures
ANOVA with Dunnet’s analysis (*Po0.05).
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thermal sensitivity was observed with CPAF treatment.
Dallob et al. (1987) also observed an increase in mechanical
sensitivity in rats treated with a subplantar injection of
synthetic PAF. Thermal stimulation was not examined in that
study. Interestingly, intrathecal injection of a PAF analog
induced both mechanical and thermal hyperalgesia (Morita
et al., 2004). It is likely that this difference in thermal
response to CPAF is related to the site of administration, and it
suggests that the actions of PAF on thermal hyperalgesia are
not necessarily mediated by PAF-R activation on primary
sensory neurons.
The role of PAF in inflammatory pain has not been well
established. PAF-Rs mediate synthesis of various inflamma-
tory mediators, including TNF-a and eicosanoids (Poubelle
et al., 1991; Ruis et al., 1991), which have been identified to
be involved in nociception and inflammatory hyperalgesia
(Richardson and Vasko, 2002). The hyperalgesic response to
PAF can be inhibited by agents that interfere with the
lipoxygenase pathway of arachidonic acid metabolism, but
appear to be resistant to inhibition of cyclooxygenase
pathway that produces prostaglandins (Dallob et al., 1987).
Therefore, it is possible that PAF and PAF-R activation plays a
role in the complex cascade involved in inflammatory hyper-
algesia. A recent report using PAF-R KO mice also demon-
strated that absence of PAF-R does not change baseline
responses to noxious mechanical and thermal stimulation
(Tusada et al., 2007). However, they demonstrated that pain-
like behavior in response to capsaicin or formalin injection,
which initiate an inflammatory response, were diminished
in PAF-R KO mice. The inflammatory response itself, as
measured by paw thickness, was not affected by a lack of the
PAF-R, suggesting differing mechanisms behind the plasma
extravasation of inflammation and hyperalgesic responses.
Ultraviolet B irradiation, as a potent oxidative stressor, has
profound biological activities. Increased pain sensitivity of
skin is one of the major symptoms of acute UVB exposure.
Irradiation of the paw with UVB induced mechanical and
thermal hyperalgesia in PAF-R-expressing wild-type mice.
UVB irradiation of epidermal cells or cellular phospholipids
produces PAF-mimetics, through oxidative fragmentation of
the glycerophosphocholines. Exposure of human keratino-
cyte-derived cell lines to UVB irradiation in the range of
400–2,000 Jm2 can produce 120–160pg of PAF/106 cells
(Marathe et al., 2005). These PAF-like species can activate
PAF-Rs in a variety of tissues. It is reasonable to speculate that
PAF-R agonists were chemically synthesized from cellular
phospholipids in mice skin exposed to UVB. The subsequent
activation of the PAF-R could stimulate the production of
inflammatory mediators, including TNF-a and eicosanoids.
Indeed, UVB irradiation of epidermal cells induces TNF-a
expression, and this process is mediated by the PAF-R
receptor (Dy et al., 1999). Administration of TNF-a can
induce both thermal and mechanical hyperalgesia (Junger
and Sorkin, 2000; Sorkin and Doom, 2000), providing a
possible mechanism for how the PAF-R could play a role in
UVB-induced inflammatory hyperalgesia. Exposure of the rat
paw to UVB irradiation also induced mechanical and thermal
hyperalgesia (Bishop et al., 2007). The alteration of thermal
and mechanical thresholds in the rats occurred at doses
of UVB exposure as low as 2,500 Jm2, and no significant
tissue damage was observed even days after the exposure.
Although these investigators did not look at time points less
than 24 hours after exposure, they did observe threshold
changes of similar magnitude to those reported here in mice
24 hours after exposure. Interestingly, the UVB-induced
hyperalgesia reported by Bishop et al. (2007) was signifi-
cantly reduced by treatment with topical or systemic
ibuprofen, a cyclooxygenase inhibitor, suggesting a signifi-
cant role for prostaglandin production in UVB-mediated
hyperalgesia.
In the PAF-R KO mice, there was a small, yet statistically
insignificant, increase in mechanical sensitivity following
UVB irradiation of the paws of PAF-R KO mice. This suggests
that the PAF system is a necessary component in the UVB-
induced mechanical hyperalgesia, but probably is not the
only mediator involved. As CPAF induced a robust mechan-
ical hyperalgesia when injected into the paw of wild-type
mice, it is possible that the PAF-R-dependant component of
UVB-induced mechanical sensitization is secondary to a
direct action of PAF on nociceptive sensory neurons.
Although there is mRNA for PAF-R in the dorsal root ganglia,
where the cell bodies of these primary sensory neurons reside
(Morita et al., 2004), it is not known which population of
these neurons express PAF-R. Different subclasses of noci-
ceptive sensory neurons mediate mechanical and thermal
stimuli (Besson and Chaouch, 1987), and the difference in
expression of PAF-R on these subclasses of neurons may
explain why CPAF treatment elicited a mechanical hyper-
algesia, but not a thermal hyperalgesia.
Although CPAF injection did not induce thermal sensitiza-
tion, UVB irradiation did elicit thermal hyperalgesia in wild-
type mice but not in mice lacking the PAF-R. This suggests
that PAF-R signaling is an important component of UVB-
induced increase in thermal sensitivity. As intrathecal injec-
tion of a PAF analog induced thermal hyperalgesia (Morita
et al., 2004), it is possible that the actions of PAF on thermal
hyperalgesia are not mediated by PAF-R activation on primary
sensory neurons, but that the PAF-R is necessary for mediation
of this response at the level of the spinal cord. Indeed, a
20minute application of 250ng of CPAF to isolated wild-type
mouse sensory neurons maintained in culture did not alter
capsaicin-stimulated release of peptide transmitters from the
cells (Hingtgen et al., unpublished data). In addition, although
CPAF induced calcium influx in isolated sensory neurons from
rat and wild-type mice, there was no evidence that CPAF
could initiate transmission of signal between the central
terminals of the primary sensory neurons and the second-
order neurons of the sensory pathway in the spinal cord slices
from wild-type mice (Tusada et al., 2007). As the TRPV1
receptor that mediates capsaicin responses on these neurons is
also important in the signaling of noxious thermal stimulation
(Caterina et al., 2000), these observations suggest that CPAF
may not have actions to directly sensitize sensory neurons to
thermal stimuli. Instead, PAF and the PAF-R on other cells in
the paw or spinal cord may be important in the production
and maintenance of other inflammatory substances, such as
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TNF-a and eicosanoids, that do elicit thermal hyperalgesia. It
is intriguing to speculate that administration of selective PAF
antagonists, such as rupatadine (Guadano et al. 2004), might
be a strategy worthy of further investigation in the treatment of
acute and chronic inflammatory pain.
As the inflammatory response to UVB irradiation is
complex and as the PAF-R is present in so many cells, it is
difficult to determine where the presence of PAF-R may be
needed for the development of hyperalgesia. The experiments
in chimeric mice help to address these issues in the in vivo
model. We have recently reported that the presence of PAF-R
in bone marrow-derived cells is necessary for UVB-induced
IL-10 production through a cyclooxygenase-dependant
mechanism likely to involve production of prostaglandins
(Zhang et al., 2008). Here, we present that the presence
of PAF-R in bone marrow-derived cells is necessary for
UVB-induced thermal hyperalgesia. As prostaglandins elicit
thermal hyperalgesia (Treede et al., 1992), it seems likely that
UVB-induced thermal hyperalgesia dependant on PAF-R
expression may be the result of prostaglandin production in
bone marrow-derived cells. In contrast, the mechanical
hyperalgesia induced by UVB was not dependant on the
expression of PAF-R in bone marrow-derived cells; it was
sufficient for PAF-R to be present in non-bone marrow-
derived cells. This suggests that there is a different compli-
ment of cells that can account for UVB-induced mechanical
hyperalgesia. Indeed, as CPAF itself was able to illicit
mechanical hyperalgesia when injected into the paw, PAF-
mimetic substances produced by UVB may act directly on
sensory neuron endings in the skin.
The biological effects of UVB on skin are of particular
interest because of the importance of UV-induced injury in
the development of photoaging, skin cancer, and inflamma-
tion, and the role of UV irradiation in the therapy of skin
disease (reviewed by Trautinger, 2001; Ichihashi et al., 2003;
Schwarz, 2002). Determining the cellular and molecular
mechanisms and finding novel factors that modulate inflam-
matory responses to acute UV absorption in epidermal cells
are important for understanding the regulation of these
processes. In this study, it was demonstrated that PAF-R is
involved in UVB-induced mechanical and thermal hyper-
algesia. Skin hyperalgesia is one of the major pathological
responses to acute UV exposure and can be measured
accurately by established behavioral methodology. Thus, the
utilization of hyperalgesia measurement in PAF-R-expressing
and KO mice models could provide an experimental strategy
to better understand the role of PAF-R as a mediator of
noxious stimulation in UVB-induced pathological conditions.
MATERIALS AND METHODS
Chemicals
Platelet-activating factor receptor agonist, CPAF, and all other
chemicals were obtained from Sigma (St Louis, MO), unless
indicated otherwise.
Animals
Platelet-activating factor receptor KO mice on a C57BL6 background
were originally and generously provided by Dr Ishii (Department of
Biochemistry and Molecular Biology, Faculty of Medicine,
The University of Tokyo). They were generated as described
previously (Ishii et al., 1998). The mice were bred in the Indiana
University Laboratory Animal Resource Center. Age-matched PAF-R-
expressing C57BL6 wild-type mice were used as controls. Mice were
8–12 weeks old at the time of testing. All mice were housed in a
pathogen-free environment and studies were approved by the
Animal Care and Use Committee of Indiana University School of
Medicine.
Mice hind paw intradermal injection of CPAF
Platelet-activating factor KO and age-matched wild-type mice were
randomly selected to receive vehicle control or CPAF injections in
the left hind paw. Behavioral testing was conducted by investigators
blinded to mouse genotype and treatment group. The baseline
mechanical and thermal sensitivity of the left hind paw was
determined. Approximately 1 hour after baseline testing, an intra-
dermal injection with 50 ml of 0.25% fatty acid-free BSA vehicle
control or 50 ml CPAF (250 or 50 ng) was administered into left hind
paw, using 30G1/2 needle (Becton Dickson, Franklin Lakes, NJ).
Mice hind paw UVB irradiation
Platelet-activating factor KO and age-matched wild-type mice were
randomly selected, and baseline thermal and mechanical sensitivity
were determined as outlined below. Approximately 1 hour later, the
mice were restrained and the left hind paw was irradiated with UVB
at the dosage of 1,500 Jm2. The UVB source was a Philips F20T12/
UV-B lamp (270–390 nm, containing 2.6% UVC, 43.6% UVB, and
53.8% UVA). The intensity of the UVB irradiation was measured
using an IL1700 radiometer and a SED240 UVB detector (Interna-
tional Light, Newburyport, MA).
Mechanical and thermal stimulation
The thresholds to mechanical stimulation were determined as
described previously using the ‘‘up–down’’ method (Chaplan et al.,
1994; Evans et al., 2000). Animals were placed on a wire mesh
platform (3mm mesh spacing) and covered with a 2,000ml clear
glass beaker. Von Frey hairs were introduced from below. Care was
taken to make sure that the animals had equilibrated to the testing
environment and that they had returned to normal activity between
introduction of stimuli. Only Von Frey hairs producing a force of
0.005 g (the smallest fiber) to 3.63 g were used. Hairs producing
force greater than 3.63 g lift the paw of the mouse. After testing for
mechanical threshold, the threshold for thermal stimuli was
determined by placing the animal in a Plexiglas box and exposing
the paw to heat from a focused projection bulb (Hargreaves et al.,
1988). The intensity of the bulb was adjusted to elicit paw
withdrawal after approximately 10 seconds in wild-type mice.
Exposure time was limited to 30 seconds to prevent tissue damage.
A mean of time to paw withdrawal was determined from three trials
of testing the same hind paw in each mouse.
Bone marrow transplantation studies
Chimeric mice were generated as described previously (Kreklau
et al., 2003). Briefly, bone marrow cells from donor mice were
harvested and transplanted into lethally irradiated recipient mice at
4 106 cells per mouse. Irradiation was delivered as a split dose of
700 cGy followed by 400 cGy delivered 4 hours later. The peripheral
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blood was harvested 4 months later via the tail vein and the
contribution of the PAF-R KO cells (CD45.2þ ) and the wild-type
(BoyJ mice, CD45.1þ ) cells were analyzed by flow cytometry. A
phycoerythrin-conjugated anti-mouse CD45.1 antibody (clone A20)
and a PerCp-Cy5.5-conjugated anti-mouse CD45.2 antibody (clone
104) were purchased from BDPharmingen (Auburn, CA) for
detection of CD45.1þ and CD45.2þ murine cells.
Statistical analysis
Results are expressed as the mean±standard error of the mean
(SEM). Differences were determined by repeated-measures ANOVA
with Dunnett’s post-hoc analysis. The significance level for all
statistical tests was Po0.05.
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